Skip to main content
. 2022 Feb 21;9(4):ofac093. doi: 10.1093/ofid/ofac093

Table 1.

Clinical Characteristics of the Patients Treated With Casirivimab-Imdevimab

Immunosuppression 37
 Solid organ transplanta 18
 Immunosuppressive treatmentb 19
Age >80 years 4
Other medical conditions 9
 Chronic kidney disease 2
 Chronic lung disease 2
 Obesity (BMI >30) + Diabetes 3
 Type 1 diabetes 1
 Chronic granulomatous disease 1

Abbreviations: BMI, body mass index.

Renal transplant (n = 11), cardiac transplant (n = 5), liver transplant (n = 2).

Anti-CD20 (n = 9), chemotherapy (n = 7), antitumor necrosis factor-α (n = 2), azathioprine (n = 1).